(Q44270173)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

chronic myeloid leukemia

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Philippa C May

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Pratap Neelakantan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Claire Lucas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dragana Milojkovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lihui Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Christos Paliompeis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marco Bua

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alistair Reid

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Katayoun Rezvani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Stephen O'Brien

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Richard Clark

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

John Goldman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David Marin

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

4 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

2739-2742

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

23 February 2020

cites work

1 reference

12 December 2020

Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia

1 reference

12 December 2020

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

1 reference

12 December 2020

Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

1 reference

12 December 2020

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib.

1 reference

12 December 2020

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival

1 reference

12 December 2020

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

12 December 2020

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

1 reference

12 December 2020

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

12 December 2020

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

1 reference

12 December 2020

10.1182/BLOOD-2012-11-466037

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23380743%20AND%20SRC:MED&resulttype=core&format=json